ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ep. 323 - Agentic AI: From New Targets to the Clinic"
Episode Synopsis
AI is bringing sweeping changes to drug development, from how targets are discovered to optimizing clinical trials to maximize an asset’s chance for success. On a special edition of the BioCentury This Week podcast, IQVIA’s Greg Lever joins BioCentury’s analysts to discuss agentic AI’s short- and long-term prospects to help biotechs discover new targets, predict success in preclinical development, and enhance clinical operations. This episode of BioCentury This Week is sponsored by IQVIA Biotech. View full story: https://www.biocentury.com/article/657086#Biotech #Biopharma #DrugDevelopment #ClinicalTrials #TargetDiscovery #AgenticAI #GraphRAG #DeRisking00:01 - Sponsor Message: IQVIA Biotech01:22 - AI in Biotech05:01 - Machine Learning06:21 - Generative AI and Language Models08:37 - Agentic AI12:43 - AI in Target Discovery23:44 - AI in Clinical Trial DesignTo submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected] us by sending a text
More episodes of the podcast BioCentury This Week
Ep. 324 - Genmab, GSK and Drug Pricing
29/09/2025
Ep. 320 - U.K. Biotech, U.S.-China, Insmed
15/09/2025
In God we trust